The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...

Studies have found important benefits from the new RSV immunization and enhanced versions of the flu shot. Plus, the shingles ...

The meeting, scheduled for June 25-26, will review existing data and vote on RSV and influenza vaccines, along with thimerosal, a preservative used in vials of medicines and vaccines. Below are ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

mNEXSPIKE - The next-generation COVID-19 vaccine was approved for aged 65 and above in May 2025. Spikevax, Moderna's first COVID-19 vaccine, received its initial FDA approval in January 2022.

by at least 11% and up to 18%. The CDC advises adults 65 and older to receive the enhanced vaccines, as many already do. More good news: Vaccines to prevent respiratory syncytial virus in people 60 ...

Deana Hendrickson, 66, who provides daily care for three young grandsons in Los Angeles, sought an additional MMR shot, ...

Updated 2023–2024 COVID-19 vaccines significantly reduced the risk of emergency visits (24%), hospitalizations (29%), and critical illness (48%) in adults, with maximum protection—up to 68% ...

A federal vaccine advisory committee plans to review the childhood vaccination schedule and scrutinize vaccines that have ...

For decades, international researchers have received a small slice of the National Institutes of Health budget. In 2024, out ...